• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Imatron to use EBT in German cardiac study

Article

Imatron has concluded an agreement with a German foundation to support a $5 million study of coronary atherosclerosis, using the company’s patented electron beam tomography technology.Researchers plan to recruit 4500 men and women from a random

Imatron has concluded an agreement with a German foundation to support a $5 million study of coronary atherosclerosis, using the company’s patented electron beam tomography technology.

Researchers plan to recruit 4500 men and women from a random sample of the general population of the Ruhr industrial district in Germany. The study will focus on the direct detection of atherosclerosis instead of on risk factors that predict the probability of the disease.

EBT coronary calcium detection scanning will be compared with other measures of atherosclerosis in other vessels such as the carotid and peripheral arteries.

Imatron’s primary product is the EBT scanner, which is now in use at more than 120 imaging facilities around the world.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.